International Plasma Awareness Week: Why it matters
An opportunity for the EU and its member states to meet growing patient need for essential medicines
healthcare systems
BE PIONEERING: The benefits of unlocking the value of diagnostic innovation in Alzheimer’s [Promoted content]
There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer’s disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to transform timely, accurate diagnosis for the benefit…
Mission Possible: Working together to reshape the future of cancer care
Q&A with Greg Rossi, Senior VP, Head of Oncology Europe and Canada at AstraZeneca.
World leaders tout AMR declaration, while NGOs sigh
SNEAK PEEK — Leaders have agreed to a political declaration on antimicrobial resistance. NGOs are disappointed, but is it really so bad? — The World Health Organization has allied with TikTok to curb the spread of health misinformation. — What will it take to be prepared for the next pandemic? It’s not looking good, Gastein […]
Who’s the real health commissioner?
SNEAK PEEK — EU health policy is now split across multiple departments, and MEPs aren’t happy. — Sort your own house out first: MEPs question Hungarian health secretary over presidency plans and country’s health commissioner role. — Spend less on defense and more on health, WHO chief Tedros told world leaders at the United Nations […]
Solid science in Europe: a farewell song?
Maintaining the highest standards is the only avenue to strengthen the EU health sector.
Time to talk sleep: Reducing the burden of chronic insomnia
Sleep deficiency is a serious health risk that profoundly affects individuals and economies yet conditions like chronic insomnia are worryingly low on the global health agenda
A Roadmap to Resilience: Building a Healthier Europe Through Investment in Mental Health [Promoted content]
The impact of mental health conditions on European societies and healthcare systems cannot be understated. Despite growing awareness within policy circles, funding remains scarce and significantly below what is required.
Act now to ensure health policies address the burgeoning demands of Myopia
One of the world’s leading vision impairments, myopia’s prevalence is set to increase, with vast implications for country’s budgets and their people’s health and well-being.
It’s time to address this leading cause of death: COPD
A new report about the global state of COPD offers insights from 30 national experts on how policy action can be implemented worldwide.
Europe’s diabetes tsunami, a crisis in full view [Advocacy Lab Content]
Europe is spending more on diabetes in a year, than on the war in Ukraine. The diabetes tsunami is a public health crisis which threatens to overwhelm healthcare systems and economic progress.
Combination therapies offer hope to cancer patients – but we need to act now to ensure access
There is an urgent need to consider solutions to overcome complex access challenges to combination therapies — payers, policymakers and industry leaders must work together and act now to ensure access.
Poland’s medical device integration gets new EMA guidance, but industry sounds caution [Advocacy Lab Content]
New guidance issued by the European Medicines Agency (EMA) on medical devices aims to streamline procedures, but integrating technologies into healthcare systems remains challenging, warns Polish industry.
New wave of radioligand therapy triggers Belgium to launch action plan [Advocacy Lab Content]
A new wave of radioligand therapies is approaching. With healthcare systems and policymakers ill-equipped to handle the change, Belgium is launching an action plan.
The Time is Now: Transforming Care in Lupus Together
An interview moderated by Robert Fogel, Vice President, Global Medical Affairs, Respiratory & Immunology, AstraZeneca, with Professor Marta Mosca and Patrick Wildman
Heat-related deaths are on the rise in Europe as the effects of climate crisis take hold
Experts say governments across Europe need to make sure their healthcare systems and infrastructures are adapting to cope with drastic climatic change.
Orphan medicines Pharma package provisions unleash uncertainties, stakeholders warn [Advocacy Lab Content]
There are more than 6,000 rare diseases, with 27 different healthcare systems governed by conflicting rules and principles, with no harmonisation for orphan medicines payments. Rare disease clinicians hope the Pharma Package will bridge regulatory gaps.
POLITICO 2024-02-05 04:00:00
References 1Institute for Health Metrics and Evaluation (2019), Global Burden of Disease (GBD) study. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed 12 September 2023. 2Fred Kleinsinger (2020), “The Unmet Challenge of Medication Nonadherence”, The Permanent Journal 22. DOI: 10.7812/TPP/18-033. Accessed 12 September 2023. 3Institut Sapiens (2023), Améliorer l’adhésion thérapeutique: un enjeu de santé publique. Available at: https://www.institutsapiens.fr/wp-content/uploads/2023/06/Ameliorer-ladhesion-therapeutique-V1.pdf Accessed […]
EU’s regional innovation balance risks widening with AI
While December’s political agreement on the AI Act could deliver a competitive edge for Europe, commercial AI consolidation risks widening the EU’s substantial regional innovation divide.